Tari Leslie
SEC insider (Form 3/4/5 filer). CIK 0001870270. CHIEF SCIENTIFIC OFFICER at Cidara Therapeutics, Inc. (CDTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Mar 11, 2025. Located in SAN DIEGO, CA.
Companies Tari Leslie has filed insider reports for
- Cidara Therapeutics, Inc. (CDTX): Officer, CHIEF SCIENTIFIC OFFICER
Tari Leslie
CIK: 0001870270
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (66.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CDTX
Cidara Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Mar 11, 2025CDTX
Cidara Therapeutics, Inc.
SaleDirect1.8K shares at avg. $21.96$39K - Sep 30, 2024CDTX
Cidara Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
150.2K shares- - Sep 11, 2024CDTX
Cidara Therapeutics, Inc.
SaleDirect909 shares at avg. $11.64$11K
1-3 of 3 transactions